{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:26:34Z","timestamp":1762507594605,"version":"3.37.3"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37 CA222885"],"award-info":[{"award-number":["R37 CA222885"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implementation Sci"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13012-018-0833-7","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:10:11Z","timestamp":1543450211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)"],"prefix":"10.1186","volume":"13","author":[{"given":"Ted A.","family":"Skolarus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah T.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela A.","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabitha","family":"Metreger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan B.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan E. V.","family":"Caram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent K.","family":"Hollenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danil V.","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy B.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahakn","family":"Shahinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Srinivasaraghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Sales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"issue":"12","key":"833_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/jnci\/djj230","volume":"98","author":"VB Shahinian","year":"2006","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst. 2006;98(12):839\u201345.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"833_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.urolonc.2009.09.004","volume":"29","author":"SM Gilbert","year":"2011","unstructured":"Gilbert SM, Kuo YF, Shahinian VB. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States. Urol Oncol. 2011;29(6):647\u201353.","journal-title":"Urol Oncol"},{"issue":"4","key":"833_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.21234","volume":"64","author":"TA Skolarus","year":"2014","unstructured":"Skolarus TA, Wolf AM, Erb NL, Brooks DD, Rivers BM, Underwood W 3rd, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64(4):225\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"833_CR4","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1056\/NEJMsa0910784","volume":"363","author":"VB Shahinian","year":"2010","unstructured":"Shahinian VB, Kuo YF, Gilbert SM. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med. 2010;363(19):1822\u201332.","journal-title":"N Engl J Med"},{"issue":"5","key":"833_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.eururo.2015.03.021","volume":"68","author":"GL Lu-Yao","year":"2015","unstructured":"Lu-Yao GL, Albertsen PC, Moore DF, Lin Y, DiPaola RS, Yao SL. Fifteen-year outcomes following conservative management among men aged 65 years or older with localized prostate Cancer. Eur Urol. 2015;68(5):805\u201311.","journal-title":"Eur Urol"},{"issue":"13","key":"833_CR6","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1200\/JCO.2013.52.5782","volume":"32","author":"AL Potosky","year":"2014","unstructured":"Potosky AL, Haque R, Cassidy-Bushrow AE, Yood MU, Jiang M, Tsai HT, et al. Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol. 2014;32(13):1324 +.","journal-title":"J Clin Oncol"},{"issue":"24","key":"833_CR7","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1002\/cncr.30948","volume":"123","author":"DD Yang","year":"2017","unstructured":"Yang DD, Mahal BA, Muralidhar V, Boldbaatar N, Labe SA, Nezolosky MD, et al. Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer. Cancer. 2017;123(24):4832\u201340.","journal-title":"Cancer"},{"issue":"6","key":"833_CR8","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.juro.2007.03.003","volume":"177","author":"I Thompson","year":"2007","unstructured":"Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106\u201331.","journal-title":"J Urol"},{"issue":"2","key":"833_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467\u201379.","journal-title":"Eur Urol"},{"issue":"1","key":"833_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124\u201337.","journal-title":"Eur Urol"},{"key":"833_CR11","unstructured":"Network NCC. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer v2.2017 [updated Feb 2017Jun 2017]. Available from: \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf\n                    \n                  ."},{"issue":"1","key":"833_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eururo.2014.10.018","volume":"68","author":"JD Sammon","year":"2015","unstructured":"Sammon JD, Abdollah F, Reznor G, Pucheril D, Choueiri TK, Hu JC, et al. Patterns of declining use and the adverse effect of primary androgen deprivation on all-cause mortality in elderly men with prostate cancer. Eur Urol. 2015;68(1):32\u20139.","journal-title":"Eur Urol"},{"issue":"3","key":"833_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.urology.2011.11.013","volume":"79","author":"VE Nambudiri","year":"2012","unstructured":"Nambudiri VE, Landrum MB, Lamont EB, McNeil BJ, Bozeman SR, Freedland SJ, et al. Understanding variation in primary prostate cancer treatment within the veterans health administration. Urology. 2012;79(3):537\u201345.","journal-title":"Urology"},{"issue":"1","key":"833_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1377\/hlthaff.2016.0739","volume":"36","author":"T Borza","year":"2017","unstructured":"Borza T, Kaufman SR, Shahinian VB, Yan P, Miller DC, Skolarus TA, et al. Sharp decline in prostate cancer treatment among men in the general population, but not among diagnosed men. Health Aff (Millwood). 2017;36(1):108\u201315.","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"833_CR15","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1200\/JCO.2006.10.1949","volume":"25","author":"DA Loblaw","year":"2007","unstructured":"Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, Mendelson DS, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007;25(12):1596\u2013605.","journal-title":"J Clin Oncol"},{"issue":"2","key":"833_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.urology.2004.03.032","volume":"64","author":"N Sato","year":"2004","unstructured":"Sato N, Akakura K, Isaka S, Nakatsu H, Tanaka M, Ito H, et al. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study. Urology. 2004;64(2):341\u20135.","journal-title":"Urology"},{"issue":"5\u20136","key":"833_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0960-0760(96)00132-X","volume":"59","author":"K Akakura","year":"1996","unstructured":"Akakura K, Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, Tenniswood M, et al. Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma. J Steroid Biochem Mol Biol. 1996;59(5\u20136):501\u201311.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"833_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jama.300.2.173","volume":"300","author":"GL Lu-Yao","year":"2008","unstructured":"Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008;300(2):173\u201381.","journal-title":"JAMA"},{"issue":"23","key":"833_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jnci\/djq419","volume":"102","author":"S Gillessen","year":"2010","unstructured":"Gillessen S, Templeton A, Marra G, Kuo YF, Valtorta E, Shahinian VB. Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. J Natl Cancer Inst. 2010;102(23):1760\u201370.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"833_CR20","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.juro.2014.12.027","volume":"193","author":"HT Tsai","year":"2015","unstructured":"Tsai HT, Keating NL, Van den Eeden SK, Haque R, Cassidy-Bushrow AE, Yood MU, et al. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer. J Urology. 2015;193(6):1956\u201362.","journal-title":"J Urology"},{"issue":"2","key":"833_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"833_CR22","first-page":"465","volume":"166","author":"VB Shahinian","year":"2006","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the \u201candrogen deprivation syndrome\u201d in men receiving androgen deprivation for prostate cancer. Arch Intern Med. 2006;166(4):465\u201371.","journal-title":"Arch Intern Med"},{"key":"833_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13012-015-0211-7","volume":"10","author":"T Montini","year":"2015","unstructured":"Montini T, Graham ID. \u201cEntrenched practices and other biases\u201d: unpacking the historical, economic, professional, and social resistance to de-implementation. Implement Sci. 2015;10:24.","journal-title":"Implement Sci"},{"key":"833_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-9-1","volume":"9","author":"V Prasad","year":"2014","unstructured":"Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci. 2014;9:1.","journal-title":"Implement Sci"},{"key":"833_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1748-5908-9-48","volume":"9","author":"VM Voorn","year":"2014","unstructured":"Voorn VM, Marang-van de Mheen PJ, So-Osman C, Kaptein AA, van der Hout A, van den Akker-van Marle ME, et al. De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial. Implement Sci. 2014;9:48.","journal-title":"Implement Sci"},{"key":"833_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1748-5908-9-58","volume":"9","author":"DC Aron","year":"2014","unstructured":"Aron DC, Lowery J, Tseng CL, Conlin P, Kahwati L. De-implementation of inappropriately tight control (of hypoglycemia) for health: protocol with an example of a research grant application. Implement Sci. 2014;9:58.","journal-title":"Implement Sci"},{"issue":"1","key":"833_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13012-017-0555-2","volume":"12","author":"DM Gupta","year":"2017","unstructured":"Gupta DM, Boland RJ Jr, Aron DC. The physician\u2019s experience of changing clinical practice: a struggle to unlearn. Implement Sci. 2017;12(1):28.","journal-title":"Implement Sci"},{"issue":"3","key":"833_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/j.1440-1800.2002.00150.x","volume":"9","author":"G Macdonald","year":"2002","unstructured":"Macdonald G. Transformative unlearning: safety, discernment and communities of learning. Nurs Inq. 2002;9(3):170\u20138.","journal-title":"Nurs Inq"},{"issue":"Suppl 2","key":"833_CR29","first-page":"ii10","volume":"13","author":"R Rushmer","year":"2004","unstructured":"Rushmer R, Davies HT. Unlearning in health care. Qual Saf Health Care. 2004;13(Suppl 2):ii10\u20135.","journal-title":"Qual Saf Health Care"},{"issue":"1","key":"833_CR30","first-page":"11","volume":"3","author":"CG Burkhart","year":"2004","unstructured":"Burkhart CG. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange. J Drugs Dermatol. 2004;3(1):11.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"833_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/J058v03n02_06","volume":"3","author":"DH Kreling","year":"1988","unstructured":"Kreling DH, Knocke DJ, Hammel RW. Changes in market shares for internal analgesic products after a Medicaid formulary restriction. J Pharm Mark Manag. 1988;3(2):65\u201376.","journal-title":"J Pharm Mark Manag"},{"issue":"12_Part_1","key":"833_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00005","volume":"128","author":"Michael W. Climo","year":"1998","unstructured":"Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide Restriction of Clindamycin: Effect on the Incidence of Clostridium difficile-Associated Diarrhea and Cost. Ann Intern Med. 1998;128(12_Part_1):989\u201395. \n                    https:\/\/doi.org\/10.7326\/0003-4819-128-12_Part_1-199806150-00005\n                    \n                  .","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"833_CR33","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/106002809202600926","volume":"26","author":"SM Baboolal","year":"1992","unstructured":"Baboolal SM, Mayo M. Comment: ketorolac formulary restriction and usage evaluation. Ann Pharmacother. 1992;26(9):1158\u201360.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"833_CR34","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1185\/03007995.2015.1060211","volume":"31","author":"X Huang","year":"2015","unstructured":"Huang X, Liu Z, Shankar RR, Rajpathak S. Description of anti-diabetic drug utilization pre- and post-formulary restriction of sitagliptin: findings from a national health plan. Curr Med Res Opin. 2015;31(8):1495\u2013500.","journal-title":"Curr Med Res Opin"},{"issue":"6\u20137","key":"833_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s002280100338","volume":"57","author":"M Bassetti","year":"2001","unstructured":"Bassetti M, Di Biagio A, Rebesco B, Amalfitano ME, Topal J, Bassetti D. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol. 2001;57(6\u20137):529\u201334.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"833_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archinte.1985.00360060117018","volume":"145","author":"JM DeVito","year":"1985","unstructured":"DeVito JM, John JF Jr. Effect of formulary restriction of cefotaxime usage. Arch Intern Med. 1985;145(6):1053\u20136.","journal-title":"Arch Intern Med"},{"issue":"1","key":"833_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00005650-198901000-00004","volume":"27","author":"DH Kreling","year":"1989","unstructured":"Kreling DH, Knocke DJ, Hammel RW. The effects of an internal analgesic formulary restriction on Medicaid drug expenditures in Wisconsin. Med Care. 1989;27(1):34\u201344.","journal-title":"Med Care"},{"issue":"8","key":"833_CR38","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.amjmed.2005.01.061","volume":"118","author":"AB O'Connor","year":"2005","unstructured":"O'Connor AB, Lang VJ, Quill TE. Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med. 2005;118(8):885\u20139.","journal-title":"Am J Med"},{"issue":"10","key":"833_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2165\/00019053-200119100-00001","volume":"19","author":"PL Hensley","year":"2001","unstructured":"Hensley PL, Nurnberg HG. Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls. PharmacoEconomics. 2001;19(10):973\u201382.","journal-title":"PharmacoEconomics"},{"issue":"3","key":"833_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0924-8579(00)00249-1","volume":"16","author":"M Bassetti","year":"2000","unstructured":"Bassetti M, Di Biagio A, Rebesco B, Cenderello G, Amalfitano ME, Bassetti D. Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. Int J Antimicrob Agents. 2000;16(3):295\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"833_CR41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/viru.21657","volume":"4","author":"EE Reed","year":"2013","unstructured":"Reed EE, Stevenson KB, West JE, Bauer KA, Goff DA. Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence. 2013;4(2):158\u201362.","journal-title":"Virulence"},{"issue":"12","key":"833_CR42","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1177\/106002809102501229","volume":"25","author":"DG Gianarkis","year":"1991","unstructured":"Gianarkis DG. Ketorolac formulary restriction and usage evaluation. DICP. 1991;25(12):1399.","journal-title":"DICP"},{"issue":"Suppl D","key":"833_CR43","first-page":"30","volume":"26","author":"RW Wetmore","year":"1991","unstructured":"Wetmore RW, Jennings RH. Retrospective analysis of formulary restriction demonstrates significant cost savings. Hospital Formul. 1991;26(Suppl D):30\u20132.","journal-title":"Hospital Formul"},{"issue":"8","key":"833_CR44","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/0272989X15597226","volume":"35","author":"M Holmes-Rovner","year":"2015","unstructured":"Holmes-Rovner M, Montgomery JS, Rovner DR, Scherer LD, Whitfield J, Kahn VC, et al. Informed decision making: assessment of the quality of physician communication about prostate cancer diagnosis and treatment. Med Decis Making. 2015;35(8):999\u20131009.","journal-title":"Med Decis Making"},{"issue":"1","key":"833_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaoncol.2014.186","volume":"1","author":"ST Hawley","year":"2015","unstructured":"Hawley ST, Jagsi R. Shared decision making in cancer care: does one size fit all? JAMA Oncol. 2015;1(1):58\u20139.","journal-title":"JAMA Oncol"},{"issue":"1","key":"833_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaoncol.2014.112","volume":"1","author":"KL Kehl","year":"2015","unstructured":"Kehl KL, Landrum MB, Arora NK, Ganz PA, van Ryn M, Mack JW, et al. Association of actual and preferred Decision roles with patient-reported quality of care: shared decision making in cancer care. JAMA Oncol. 2015;1(1):50\u20138.","journal-title":"JAMA Oncol"},{"key":"833_CR47","doi-asserted-by":"publisher","first-page":"a1655","DOI":"10.1136\/bmj.a1655","volume":"337","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.","journal-title":"BMJ"},{"key":"833_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1748-5908-8-111","volume":"8","author":"J Dyson","year":"2013","unstructured":"Dyson J, Lawton R, Jackson C, Cheater F. Development of a theory-based instrument to identify barriers and levers to best hand hygiene practice among healthcare practitioners. Implement Sci. 2013;8:111.","journal-title":"Implement Sci"},{"issue":"1","key":"833_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/qshc.2004.011155","volume":"14","author":"S Michie","year":"2005","unstructured":"Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A, et al. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26\u201333.","journal-title":"Qual Saf Health Care"},{"issue":"1","key":"833_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1748-5908-7-38","volume":"7","author":"SD French","year":"2012","unstructured":"French SD, Green SE, O'Connor DA, McKenzie JE, Francis JJ, Michie S, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implement Sci. 2012;7(1):38.","journal-title":"Implement Sci"},{"key":"833_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1748-5908-9-33","volume":"9","author":"JM Huijg","year":"2014","unstructured":"Huijg JM, Gebhardt WA, Dusseldorp E, Verheijden MW, van der Zouwe N, Middelkoop BJ, et al. Measuring determinants of implementation behavior: psychometric properties of a questionnaire based on the theoretical domains framework. Implement Sci. 2014;9:33.","journal-title":"Implement Sci"},{"key":"833_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1748-5908-9-11","volume":"9","author":"JM Huijg","year":"2014","unstructured":"Huijg JM, Gebhardt WA, Crone MR, Dusseldorp E, Presseau J. Discriminant content validity of a theoretical domains framework questionnaire for use in implementation research. Implement Sci. 2014;9:11.","journal-title":"Implement Sci"},{"key":"833_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13012-014-0092-1","volume":"9","author":"NJ Gould","year":"2014","unstructured":"Gould NJ, Lorencatto F, Stanworth SJ, Michie S, Prior ME, Glidewell L, et al. Application of theory to enhance audit and feedback interventions to increase the uptake of evidence-based transfusion practice: an intervention development protocol. Implement Sci. 2014;9:92.","journal-title":"Implement Sci"},{"issue":"5","key":"833_CR54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ajic.2013.12.022","volume":"42","author":"J McAteer","year":"2014","unstructured":"McAteer J, Stone S, Fuller C, Michie S. Using psychological theory to understand the challenges facing staff delivering a ward-led intervention to increase hand hygiene behavior: a qualitative study. Am J Infect Control. 2014;42(5):495\u20139.","journal-title":"Am J Infect Control"},{"key":"833_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13012-015-0300-7","volume":"10","author":"S Steinmo","year":"2015","unstructured":"Steinmo S, Fuller C, Stone SP, Michie S. Characterising an implementation intervention in terms of behaviour change techniques and theory: the \u2018Sepsis Six\u2019 clinical care bundle. Implement Sci. 2015;10:111.","journal-title":"Implement Sci"},{"issue":"3","key":"833_CR56","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/bmjqs-2014-003627","volume":"24","author":"F Davidoff","year":"2015","unstructured":"Davidoff F, Dixon-Woods M, Leviton L, Michie S. Demystifying theory and its use in improvement. BMJ Qual Saf. 2015;24(3):228\u201338.","journal-title":"BMJ Qual Saf"},{"key":"833_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1748-5908-3-34","volume":"3","author":"SR Kirsh","year":"2008","unstructured":"Kirsh SR, Lawrence RH, Aron DC. Tailoring an intervention to the context and system redesign related to the intervention: a case study of implementing shared medical appointments for diabetes. Implement Sci. 2008;3:34.","journal-title":"Implement Sci"},{"key":"833_CR58","unstructured":"Complex Interventions in Health: an overview of research methods. Edited by David A. Richards, Ingalill Rahm Hallberg. \u00a9 2015 \u2013 Routledge."},{"issue":"2","key":"833_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hec.1697","volume":"21","author":"EW de Bekker-Grob","year":"2012","unstructured":"de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145\u201372.","journal-title":"Health Econ"},{"issue":"1","key":"833_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13012-017-0675-8","volume":"12","author":"RG Salloum","year":"2017","unstructured":"Salloum RG, Shenkman EA, Louviere JJ, Chambers DA. Application of discrete choice experiments to enhance stakeholder engagement as a strategy for advancing implementation: a systematic review. Implement Sci. 2017;12(1):140.","journal-title":"Implement Sci"},{"issue":"7436","key":"833_CR61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/bmj.328.7436.360","volume":"328","author":"M Ryan","year":"2004","unstructured":"Ryan M. Discrete choice experiments in health care. BMJ. 2004;328(7436):360\u20131.","journal-title":"BMJ"},{"issue":"1","key":"833_CR62","first-page":"55","volume":"2","author":"M Ryan","year":"2003","unstructured":"Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55\u201364.","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"833_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"F Reed Johnson","year":"2013","unstructured":"Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Muhlbacher A, Regier DA, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3\u201313.","journal-title":"Value Health"},{"key":"833_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1748-5908-7-37","volume":"7","author":"J Cane","year":"2012","unstructured":"Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implementation science : IS. 2012;7:37.","journal-title":"Implementation science : IS."},{"key":"833_CR65","doi-asserted-by":"publisher","unstructured":"Atkins L1, Francis J2,3, Islam R3, O'Connor D4, Patey A3, Ivers N5, Foy R6, Duncan EM7, Colquhoun H8, Grimshaw JM3,9, Lawton R10, Michie S11. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. \n                    https:\/\/doi.org\/10.1186\/s13012-017-0605-9\n                    \n                  .","DOI":"10.1186\/s13012-017-0605-9"},{"issue":"2","key":"833_CR66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health. 2011;38(2):65\u201376.","journal-title":"Admin Pol Ment Health"},{"issue":"2","key":"833_CR67","first-page":"77","volume":"14","author":"AR Mitchinson","year":"2008","unstructured":"Mitchinson AR, Kerr EA, Krein SL. Management of chronic noncancer pain by VA primary care providers: when is pain control a priority? Am J Manag Care. 2008;14(2):77\u201384.","journal-title":"Am J Manag Care"},{"issue":"1","key":"833_CR68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13063-017-1925-4","volume":"18","author":"TA Skolarus","year":"2017","unstructured":"Skolarus TA, Metreger T, Hwang S, Kim HM, Grubb RL 3rd, Gingrich JR, et al. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 2017;18(1):181.","journal-title":"Trials"},{"key":"833_CR69","volume-title":"Mail and internet surveys: the tailored design method","author":"D Dillman","year":"2000","unstructured":"Dillman D. Mail and internet surveys: the tailored design method. New York: Wiley; 2000."},{"issue":"2","key":"833_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","volume":"10","author":"GA Lancaster","year":"2004","unstructured":"Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10(2):307\u201312.","journal-title":"J Eval Clin Pract"},{"key":"833_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1748-5908-7-35","volume":"7","author":"JJ Francis","year":"2012","unstructured":"Francis JJ, O'Connor D, Curran J. Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework. Implement Sci. 2012;7:35.","journal-title":"Implement Sci"},{"key":"833_CR72","unstructured":"The behaviour change wheel: a guide to designing interventions. Copyright \u00a9 Susan Michie, Lou Atkins and Robert West Silverback Publishing 2014."},{"issue":"1","key":"833_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12160-013-9486-6","volume":"46","author":"S Michie","year":"2013","unstructured":"Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81\u201395.","journal-title":"Ann Behav Med"},{"key":"833_CR74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13012-014-0167-z","volume":"9","author":"SA Birken","year":"2014","unstructured":"Birken SA, Presseau J, Ellis SD, Gerstel AA, Mayer DK. Potential determinants of health-care professionals\u2019 use of survivorship care plans: a qualitative study using the theoretical domains framework. Implement Sci. 2014;9:167.","journal-title":"Implement Sci"},{"key":"833_CR75","volume-title":"Qualitative research and evaluation methods","author":"MQ Patton","year":"2002","unstructured":"Patton MQ. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks: Sage Publications; 2002.","edition":"3"},{"issue":"9","key":"833_CR76","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40273-014-0170-x","volume":"32","author":"MD Clark","year":"2014","unstructured":"Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. PharmacoEconomics. 2014;32(9):883\u2013902.","journal-title":"PharmacoEconomics"},{"issue":"6","key":"833_CR77","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1111\/hex.12301","volume":"18","author":"Kirsten Howard","year":"2014","unstructured":"Howard K, Salkeld GP, Patel MI, Mann GJ, Pignone MP. Men\u2019s preferences and trade-offs for prostate cancer screening: a discrete choice experiment. Health Expect. 2015;18:3123\u201335.","journal-title":"Health Expectations"},{"key":"833_CR78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-9-69","volume":"9","author":"MH Struik","year":"2014","unstructured":"Struik MH, Koster F, Schuit AJ, Nugteren R, Veldwijk J, Lambooij MS. The preferences of users of electronic medical records in hospitals: quantifying the relative importance of barriers and facilitators of an innovation. Implement Sci. 2014;9:69.","journal-title":"Implement Sci"},{"issue":"7404","key":"833_CR79","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/bmj.326.7404.1432","volume":"326","author":"C Ubach","year":"2003","unstructured":"Ubach C, Scott A, French F, Awramenko M, Needham G. What do hospital consultants value about their jobs? A discrete choice experiment. BMJ. 2003;326(7404):1432.","journal-title":"BMJ"},{"issue":"2","key":"833_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1741-6787.2004.04023.x","volume":"1","author":"ND Sharp","year":"2004","unstructured":"Sharp ND, Pineros SL, Hsu C, Starks H, Sales AE. A qualitative study to identify barriers and facilitators to implementation of pilot interventions in the veterans health administration (VHA) northwest network. Worldviews Evid-Based Nurs. 2004;1(2):129\u201339.","journal-title":"Worldviews Evid-Based Nurs"}],"container-title":["Implementation Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-018-0833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13012-018-0833-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-018-0833-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:57:29Z","timestamp":1589543849000},"score":1,"resource":{"primary":{"URL":"https:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-018-0833-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1186\/s13012-018-0833-7","relation":{},"ISSN":["1748-5908"],"issn-type":[{"type":"electronic","value":"1748-5908"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the VA Ann Arbor Healthcare System IRB (IRB-2017-1047) and the University of Michigan IRB (HUM00133932). As this study is conducted solely by phone and by mail and is considered minimal risk, a waiver of documentation of signed informed consent and HIPAA Authorization was approved. Verbal informed consent is obtained for all patients participating in the research. Further information and documentation on IRB approval is available upon request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. Dr. Skolarus is a prostate cancer survivorship author for UpToDate\u2122.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"144"}}